Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.38
Delayed Data
As of 3:59pm ET
 +0.07 / +0.96%
Today’s Change
5.85
Today|||52-Week Range
11.34
-18.00%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a +171.00% increase from the last price of 7.38.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Oramed Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$618.0K
Reporting Date
Apr 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -31.11%
 
 
 
 
 
 
Growthannually -49.68%
 
 
 
 
 
 

Sales

Growthquarterly 1.15%
 
 
 
 
 
 
Growthannually 7.21%
 
 
 
 
 
Key to the earnings and sales forecast charts.